What is Sunitinib used for?

Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications.
Sunitinib inhibits cellular signaling by targeting multiple receptor tyrosine kinases (RTKs).
Source Content : wikipedia

Drug procurement of Sunitinib brands in India, sold by Indian Drug Manufacturer. Please call at M: +91 9811747774 or Email Us to know more details about the medicine and its cost price in India.

Get In Touch

Sunitinib suppliers & wholesalers in India

Head Office of Indian Pharma Network (IPN) is in New Delhi, INDIA.
For Indian Patients Sutent (Sunitinib) can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India.
For overseas patient Sutent (Sunitinib) brands in India can be also made available to overseas patients, doctors and hospitals. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Sunitinib Brands In India

1. Sutent (Sunitinib) Capsules

For More Details

Dosage Forms and Strengths

Sunitinib Biosimilar Medicine approved and marketed in India is available as 12.5 mg, 25 mg, 50 mg capsules.